Direxion Daily S&P Biotech Bull 3X Shares (LABU)
NYSEARCA: LABU · Real-Time Price · USD
62.36
-5.28 (-7.81%)
Jul 15, 2025, 4:00 PM - Market closed
LABU Holdings Information
LABU is an equity ETF with a total of 137 individual holdings. The top holdings are Dreyfus Govt Cash Man Ins stock at 19.95%, S&P Biotechnology Select Industry Index Swap at 14.82%, Goldman Sachs Sterling FixInc Port at 14.03%, Goldman Sachs Fin Gov 465 Institut at 8.68%, and Dreyfus Trsry Securities Cash Mgmt at 3.11%.
Total Holdings
137
Top 10 Percentage
67.73%
Asset Class
Equity
ETF Category
Trading--Leveraged Equity
Assets
671.40M
PE Ratio
n/a
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | n/a | Dreyfus Govt Cash Man Ins | 19.95% |
| 2 | n/a | S&P Biotechnology Select Industry Index Swap | 14.82% |
| 3 | n/a | Goldman Sachs Sterling FixInc Port Inc | 14.03% |
| 4 | n/a | Goldman Sachs Fin Gov 465 Institut | 8.68% |
| 5 | n/a | Dreyfus Trsry Securities Cash Mgmt | 3.11% |
| 6 | MRNA | Moderna, Inc. | 1.58% |
| 7 | EXEL | Exelixis, Inc. | 1.40% |
| 8 | NBIX | Neurocrine Biosciences, Inc. | 1.39% |
| 9 | UTHR | United Therapeutics Corporation | 1.39% |
| 10 | ALNY | Alnylam Pharmaceuticals, Inc. | 1.38% |
| 11 | REGN | Regeneron Pharmaceuticals, Inc. | 1.38% |
| 12 | HALO | Halozyme Therapeutics, Inc. | 1.37% |
| 13 | VRTX | Vertex Pharmaceuticals Incorporated | 1.36% |
| 14 | GILD | Gilead Sciences, Inc. | 1.34% |
| 15 | AMGN | Amgen Inc. | 1.32% |
| 16 | BMRN | BioMarin Pharmaceutical Inc. | 1.32% |
| 17 | INCY | Incyte Corporation | 1.31% |
| 18 | ABBV | AbbVie Inc. | 1.30% |
| 19 | BIIB | Biogen Inc. | 1.30% |
| 20 | INSM | Insmed Incorporated | 1.26% |
| 21 | NTRA | Natera, Inc. | 1.25% |
| 22 | EXAS | Exact Sciences Corporation | 1.23% |
| 23 | BBIO | BridgeBio Pharma, Inc. | 1.21% |
| 24 | BPMC | Blueprint Medicines Corporation | 1.04% |
| 25 | MDGL | Madrigal Pharmaceuticals, Inc. | 1.03% |
As of Jul 10, 2025